Therapeutic Role of MiR-140-5p for the Treatment of Non-small Cell Lung Cancer.
@article{Flamini2017TherapeuticRO, title={Therapeutic Role of MiR-140-5p for the Treatment of Non-small Cell Lung Cancer.}, author={Valentina Flamini and Wen Jiang and Yuxin Cui}, journal={Anticancer research}, year={2017}, volume={37 8}, pages={ 4319-4327 } }
BACKGROUND/AIM
Lung cancer is the second most common cancer in both men and women, after prostate and breast cancer, respectively. There are two main types of primary lung cancer, non-small cell lung cancer (NSCLC), which accounts for approximately 85-90% of all lung cancer cases, and small cell lung cancer (SCLC), which accounts for the other 10-15% of lung cancers. MiRNAs are small molecules that post-transcriptionally regulate many genes and contribute to many disease aetiologies, including… CONTINUE READING
Topics from this paper.
Citations
Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS
Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target
VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED
Effect of miR-140-5p on the regulation of proliferation and apoptosis in NSCLC and its underlying mechanism.
VIEW 5 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED
Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells
VIEW 4 EXCERPTS
CITES BACKGROUND & RESULTS
The Network of Non-coding RNAs in Cancer Drug Resistance
VIEW 1 EXCERPT
CITES BACKGROUND